InvestWiserStrategic Partners A/S
STRAP · Nasdaq Copenhagen · Healthcare
700.00DKK
+2.9%last day
Price as of 2 October 2026
Performance
1 month
−5.4%
1 year
−35.8%
3 years, per year
−17.7%
5 years, per year
−52.8%
Largest fall, 3 years
−99.3%
Below the peak now
−99.5%
Volatility, 1 year
70.1%
Return with dividends reinvested.
Key figures
P/E
21.4
P/B
1.5
Dividend yield
0.0%
Return on equity
+6.9%
Net margin
–
Market value
4 m USD
Quality, value and trend
Where Strategic Partners stands against every Nordic stock today. 100 is best.
83
Profitability and a sound balance sheet over time. Better than 83% of Nordic stocks.
34
The price measured against earnings, assets and cash flow. Better than 34% of Nordic stocks.
65
The price development over the past year. Better than 65% of Nordic stocks.
68
Quality, value and trend together. Better than 68% of Nordic stocks.
About Strategic Partners
Strategic Partners A/S is a company in healthcare, listed on Nasdaq Copenhagen. The share trades in DKK. It has around 1 employees.
Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024. Strategic Partners A/S was incorporated in 2009 and is based in Herlev, Denmark.
See the full analysis in InvestWiser.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
See the full analysis